138 related articles for article (PubMed ID: 35777066)
1. I-131 false-positive uptake in a thymic cyst with expression of the sodium-iodide symporter: A case report.
Yano E; Nakajo M; Jinguji M; Tani A; Kitazono I; Yoshiura T
Medicine (Baltimore); 2022 Jul; 101(26):e29282. PubMed ID: 35777066
[TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
3. Nabothian cyst associated with high false-positive incidence of iodine-131 uptake in whole-body scans after treatment for differentiated thyroid cancer.
Liu S; Zhang M; Pan Y; Qu Q; Wu H; Lv J; Zhang Y
Nucl Med Commun; 2013 Dec; 34(12):1204-7. PubMed ID: 24077637
[TBL] [Abstract][Full Text] [Related]
4. [Iodine 131 uptake by a bronchogenic cyst in a patient with differentiated carcinoma of the thyroid gland].
Lejeune M; Héron C; Tenenbaum F; Sarfati PO; Louvel A; Luton JP; Richard B
Presse Med; 2000 Jul 8-15; 29(24):1345-7. PubMed ID: 10938686
[TBL] [Abstract][Full Text] [Related]
5. False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer.
Jang HY; Kim BH; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
Intern Med; 2013; 52(20):2321-3. PubMed ID: 24126393
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid cancer theranostics: radioiodine and beyond.
Choudhury PS; Gupta M
Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Mishra A; Pal L; Mishra SK
World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
[TBL] [Abstract][Full Text] [Related]
9. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
[TBL] [Abstract][Full Text] [Related]
10. Orbital Radioiodine Uptake in Epithelial Conjunctival Inclusion Cyst on Scintigraphy in a Patient With Differentiated Thyroid Cancer.
Makarewicz M; Skierkowski W; Makarewicz J
Clin Nucl Med; 2023 Aug; 48(8):e382-e384. PubMed ID: 37220222
[TBL] [Abstract][Full Text] [Related]
11. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium iodide symporter protein on ablation success in patients with differentiated thyroid cancer.
Mutevelızade G; Kocer NE; Reyhan M
Ann Nucl Med; 2022 Dec; 36(12):1050-1058. PubMed ID: 36214955
[TBL] [Abstract][Full Text] [Related]
13. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
Muros MA; Llamas-Elvira JM; Ramírez-Navarro A; Gómez MJ; Rodríguez-Fernández A; Muros T; López de la Torre M; Becerra A; Carreras JL
Am J Surg; 2000 Jun; 179(6):457-61. PubMed ID: 11004330
[TBL] [Abstract][Full Text] [Related]
14. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
Rubello D; Mazzarotto R; Casara D
Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients.
Yildirim-Poyraz N; Yazgan A; Ozdemir E; Gozalan A; Keskin M; Ersoy R; Turkolmez S; Cakir B
Ann Nucl Med; 2014 Aug; 28(7):623-31. PubMed ID: 24823701
[TBL] [Abstract][Full Text] [Related]
16. 131I and 124I Accumulation in a Thymic Cyst.
Wilhelm T; Winkens T; Kunze A; Freesmeyer M
Clin Nucl Med; 2016 Dec; 41(12):972-974. PubMed ID: 27749419
[TBL] [Abstract][Full Text] [Related]
17. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients.
Tatar FA; Morita E; Ituarte PH; Cavalieri RR; Duh QY; Price DC; Siperstein AE; Clark OH
World J Surg; 2001 Jun; 25(6):718-22. PubMed ID: 11376405
[TBL] [Abstract][Full Text] [Related]
18. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
[TBL] [Abstract][Full Text] [Related]
19. False-positive radioiodine whole-body scan due to a renal cyst.
Maciejewski A; Czepczyński R; Ruchała M
Endokrynol Pol; 2018; 69(6):736-739. PubMed ID: 30306537
[TBL] [Abstract][Full Text] [Related]
20. Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature.
Campennì A; Giovinazzo S; Tuccari G; Fogliani S; Ruggeri RM; Baldari S
Arch Endocrinol Metab; 2015 Aug; 59(4):351-4. PubMed ID: 26331324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
